ストックスクリーナーアプリを入手
8.04
3.61%
0.28
アフターアワーズ：
8.00
-0.04
-0.50%
前日終値:
$7.76
開ける：
$7.76
24時間の取引高:
1.89M
Relative Volume:
2.43
時価総額：
$599.09M
収益：
-
当期純損益:
$-27.03M
株価収益率:
-14.36
EPS:
-0.56
ネットキャッシュフロー:
$-23.97M
1週間 パフォーマンス:
+9.39%
1か月 パフォーマンス:
+9.09%
6か月 パフォーマンス:
+123.96%
1年 パフォーマンス:
-9.05%
1日の値動き範囲:
$7.50
$8.44
1週間の範囲:
$7.40
$8.44
52週間の値動き範囲:
$2.54
$10.00
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
名前
Corvus Pharmaceuticals Inc
セクター
電話
(650) 900-4520
住所
863 MITTEN ROAD, BURLINGAME, CA
CRVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
8.04 | 578.23M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-01-02 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-18 | 開始されました | Oppenheimer | Outperform |
| 2021-12-01 | 再開されました | Jefferies | Buy |
| 2021-05-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-02-10 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-05-29 | 開始されました | ROTH Capital | Buy |
| 2017-08-24 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2017-05-01 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2016-04-18 | 開始されました | Credit Suisse | Outperform |
| 2016-04-18 | 開始されました | Guggenheim | Buy |
すべてを表示
Corvus Pharmaceuticals Inc (CRVS) 最新ニュース
Is Corvus Pharmaceuticals Inc. forming a bottoming base2025 Big Picture & Verified Entry Point Signals - newser.com
What momentum indicators show for Corvus Pharmaceuticals Inc. stockJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Corvus Pharmaceuticals Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
What technical models suggest about Corvus Pharmaceuticals Inc.’s comebackWeekly Investment Summary & Safe Capital Growth Tips - newser.com
How to build a dashboard for Corvus Pharmaceuticals Inc. stockMarket Trend Review & Technical Buy Zone Confirmations - newser.com
Is Corvus Pharmaceuticals Inc. stock a defensive play in 2025July 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Combining price and volume data for Corvus Pharmaceuticals Inc.Quarterly Earnings Report & Fast Exit and Entry Trade Guides - newser.com
Why Corvus Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Corvus Pharmaceuticals Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Corvus Pharmaceuticals (CRVS) Expected to Announce Earnings on Tuesday - MarketBeat
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
What machine learning models say about Corvus Pharmaceuticals Inc.M&A Rumor & Fast Exit Strategy with Risk Control - newser.com
Real time social sentiment graph for Corvus Pharmaceuticals Inc.Weekly Trend Summary & Community Consensus Stock Picks - newser.com
Corvus Pharmaceuticals, Inc. (CRVS) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Corvus Pharmaceuticals, Inc. (CRVS) Analyst insights, Price targets and Recommendations - Yahoo! Finance Singapore
Corvus Pharmaceuticals Inc. recovery potential after sell offEarnings Performance Report & Verified Short-Term Plans - newser.com
Corvus Pharmaceuticals Inc. stock momentum explained2025 Analyst Calls & Precise Buy Zone Tips - newser.com
ETFs Investing in Corvus Pharmaceuticals, Inc. Stocks - TradingView
Will Corvus Pharmaceuticals Inc. stock benefit from green energy trendsEarnings Risk Report & Growth Focused Entry Reports - Fundação Cultural do Pará
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025 - The Manila Times
Corvus Pharma (NASDAQ: CRVS) to host Nov. 4 webcast for financial results update - Stock Titan
How Corvus Pharmaceuticals Inc. stock reacts to Fed rate cuts - fcp.pa.gov.br
Will Corvus Pharmaceuticals Inc. stock remain a Wall Street favoriteWeekly Earnings Recap & AI Based Trade Execution Alerts - fcp.pa.gov.br
Using RSI to spot recovery in Corvus Pharmaceuticals Inc.Analyst Downgrade & Safe Swing Trade Setup Alerts - newser.com
Aug Summary: Why Corvus Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Selloffs & Real-Time Stock Price Movement Reports - fcp.pa.gov.br
Corvus Pharmaceuticals’ Soquelitinib Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks
Why Corvus Pharmaceuticals Inc. stock is a value investor pickTrade Risk Report & Fast Exit and Entry Trade Guides - fcp.pa.gov.br
Corvus Pharmaceuticals Inc (CRVS) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):